Viewing StudyNCT06360861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:23 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06360861
Status: COMPLETED
Last Update Posted: 2024-04-11
First Post: 2024-03-17
Brief Title: Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Sponsor: Tehran University of Medical Sciences
Organization: Tehran University of Medical Sciences
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Mesenchymal Stem Cells
Multiple Sclerosis
Secondary-Progressive Multiple Sclerosis
Keywords:
Name View
Autoimmune Disease View
Mesenchymal Stem cells View
Multiple Sclerosis View
Placenta derived Mesenchymal Stem Cells View
Stem Cell therapy View
Neuroimmunology View